These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8897079)

  • 1. Calciumantagonistic effect of natural and synthetic estrogens--investigations on a nongenomic mechanism of direct vascular action.
    Mueck AO; Seeger H; Lippert TH
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):424-6. PubMed ID: 8897079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic estrogens-mediated activation of JNK intracellular signaling molecule.
    Prifti S; Mall P; Strowitzki T; Rabe T
    Gynecol Endocrinol; 2001 Apr; 15(2):135-41. PubMed ID: 11379010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
    Seeger H; Mück AO; Lorkowski G; Teichmann AT; Lippert TH
    Contraception; 1996 Oct; 54(4):265-8. PubMed ID: 8922881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
    Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct action of estrone on vascular tissue involves genomic and non-genomic actions.
    Rauschemberger MB; Sellés J; Massheimer V
    Life Sci; 2008 Jan; 82(1-2):115-23. PubMed ID: 18061209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone].
    Mueck AO; Seeger H; Wallwiener D
    Zentralbl Gynakol; 2001 Nov; 123(11):648-54. PubMed ID: 11797164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical relevance of drug interactions between sexual steroids and other medications].
    Mueck AO; Römer T
    Zentralbl Gynakol; 2000; 122(3):141-9. PubMed ID: 10756597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of 9 beta-estrogens.
    Gabbard RB; Segaloff A
    Steroids; 1983 Nov; 42(5):555-63. PubMed ID: 6680929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol.
    Hyder SM; Chiappetta C; Stancel GM
    J Pharmacol Exp Ther; 1999 Aug; 290(2):740-7. PubMed ID: 10411586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application.
    Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate.
    Akarasereenont P; Tripatara P; Chotewuttakorn S; Palo T; Thaworn A
    Platelets; 2006 Nov; 17(7):441-7. PubMed ID: 17074719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and synthetic oestrogens in the female climacteric.
    Practitioner; 1977 Apr; 218(1306):573-9. PubMed ID: 323841
    [No Abstract]   [Full Text] [Related]  

  • 15. 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males.
    Dai-Do D; Espinosa E; Liu G; Rabelink TJ; Julmy F; Yang Z; Mahler F; Lüscher TF
    Cardiovasc Res; 1996 Nov; 32(5):980-5. PubMed ID: 8944830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What happens in our patients' bodies to the steroid hormones we prescribe? Pt. 1. Estrogens].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1981 Oct; 9(10):623-9. PubMed ID: 12311060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells.
    Yang Z; Cheng B; Song J; Wan Y; Wang Q; Cheng B; Chen X
    Int J Cardiol; 2007 Jun; 118(3):381-8. PubMed ID: 17055086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with 17beta-estradiol increases susceptibility of smooth muscle cells to nitric oxide.
    Egami R; Tanaka Y; Nozaki M; Koera K; Okuma A; Nakano H
    Eur J Pharmacol; 2005 Sep; 520(1-3):142-9. PubMed ID: 16135361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A.
    Somjen D; Kohen F; Lieberherr M; Gayer B; Schejter E; Katzburg S; Limor R; Sharon O; Knoll E; Posner GH; Kaye AM; Stern N
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):293-303. PubMed ID: 15860273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.